Kriya Therapeutics, Inc. — Form D

Kriya Therapeutics, Inc. of MORRISVILLE, NC, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-14. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
DANIEL CHENExecutive OfficerSan Mateo, CA
James MomtazeeDirectorMenlo Park, CA
Neelaksh VarshneyDirectorMorrisville, NC
Michele StoneExecutive OfficerMorrisville, NC
Ilan OrenDirectorMorrisville, NC
Saira RamasastryDirectorRaleigh, NC
Ryan GallagherDirectorCorona Del Mar, CA
Keith ManchesterDirectorMorrisville, NC
Katherine EadeExecutive OfficerMorrisville, NC
Akshay RaiDirectorMorrisville, NC
Shankar RamaswamyDirectorMorrisville, NC
Shankar RamaswamyExecutive OfficerMorrisville, NC
Curt HerbertsExecutive OfficerMorrisville, NC
Britt PettyExecutive OfficerMorrisville, NC
Roger JeffsDirectorMorrisville, NC
Brian FurmanskiExecutive OfficerMorrisville, NC
Trit GargDirectorMorrisville, NC
Dana JohnsonExecutive OfficerPalo Alto, CA
Neera RavindranExecutive OfficerRedwood City, CA
Ilise LombardoExecutive OfficerRedwood City, CA
C.R. SincockDirectorRedwood City, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2025-09-10D/A$320.8M$320.8M
2025-08-15D$313.3M$313.3M
2023-07-27D/A$432.0M$361.8M
2022-05-24D$300.5M$270.5M
2020-08-18D/A$87.6M$87.6M
2020-05-19D$85.6M$85.6M

More